-
Anyone can drown. No one should. Lancet Public Health (IF 25.4) Pub Date : 2025-01-02
“Anyone can drown. No one should.” notes WHO Director General Tedros Adhanom Ghebreyesus, in his foreword to the first WHO Global status report on drowning prevention, released on Dec 13, 2024. Following on from the recommendations of the UN resolution on drowning prevention, championed by the Governments of Bangladesh and Ireland and the 2023 World Health Assembly resolution on accelerating action
-
Mortality in survivors of adolescent and young adult cancer: progress and opportunities Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Michael E Roth, Amy M Berkman
Survivors of adolescent and young adult (AYA) cancer (ie, those aged 15 to 39 years at diagnosis) are a large and growing population. There are more than 2 million survivors of AYA cancer in the USA alone,1 and efforts targeted at reducing late morbidity and mortality are urgently needed. In The Lancet Public Health, Taylor Hughes and colleagues2 evaluate the risk of mortality after a diagnosis of
-
Overall and late mortality among 24 459 survivors of adolescent and young adult cancer in Alberta, Canada: a population-based cohort study Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Taylor Hughes, Ruth L Diaz, Sarah McKillop, Paul C Nathan, Miranda M Fidler-Benaoudia
BackgroundAdolescent and young adult (AYA) cancer survivors are at an increased risk of premature mortality due to their cancer and its treatment. Herein, we aimed to quantify the excess risks of mortality among AYA cancer survivors and identify target populations for intervention. MethodsThe Alberta AYA Cancer Survivor Study is a retrospective, population-based cohort of individuals diagnosed with
-
The SARS-CoV-2 test scale-up in the USA: an analysis of the number of tests produced and used over time and their modelled impact on the COVID-19 pandemic Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Steven Santos, Matthew Humbard, Anastasia S Lambrou, Gary Lin, Yamil Padilla, Jasmine Chaitram, Muktha S Natrajan, Hannah L Kirking, Sean Courtney, Kim Del Guercio, Seth Roberts, Fraser Gaspar, Michael F Iademarco, Joseph Hamel, Reynolds M Salerno
BackgroundRapid, accessible, and accurate testing was paramount to an effective US COVID-19 response. Federal partners supported SARS-CoV-2 testing scale-up through an interagency-coordinated approach that focused on expanding supply chains, research and development, validation, and improving patient access. We aimed to provide an overview of the federal efforts to scale up the testing response and
-
The public health risks of counterfeit pills Lancet Public Health (IF 25.4) Pub Date : 2025-01-02 Joseph Friedman, Daniel Ciccarone
Synthetic illicit drugs, such as nitazenes and fentanyls, are becoming commonplace in countries around the world, including in Europe, Australia, and Latin America, which raises concern for overdose crises like those seen in North America. An important dimension of the risk represented by synthetic drugs is the fact that they are increasingly packaged in counterfeit pill form. These pills—often indistinguishable
-
Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons Lancet Public Health (IF 25.4) Pub Date : 2024-12-16 Nadine Kronfli MD, Daniel J Bromberg MSc, Prof Hans Wolff MD, Linda Montanari MSc, Serheii Vasyliev MD, Prof Frederick L Altice MD
The 1990 resolution by the UN General Assembly committed member states to provide health-care equity for people in prison, who are included in the global goals to control HIV and eliminate hepatitis C virus (HCV) by 2030. WHO has set ambitious HCV elimination targets by including people who inject drugs (PWID), yet has not prioritised PWID who are incarcerated, a substantial population who have or
-
Early childhood adversity associated with high-intensity public service use Lancet Public Health (IF 25.4) Pub Date : 2024-12-13 Nicole Racine, Andrea Evans
Experiences of early childhood adversity are common, with 1 in 6 children having high levels of adversity in their childhood.1 These exposures have detrimental effects on children's health and developmental trajectories and are associated with poor physical and mental health outcomes across the life course.2 Individuals exposed to high levels of childhood adversity might require increased support and
-
Association between childhood adversity and use of the health, social, and justice systems in Denmark (DANLIFE): a nationwide cohort study Lancet Public Health (IF 25.4) Pub Date : 2024-12-13 Bertina Kreshpaj PhD, Leonie K Elsenburg PhD, Prof Signe Hald Andersen PhD, Tjeerd Rudmer De Vries PhD, Karsten Thielen PhD, Prof Naja Hulvej Rod DMSc
Childhood adversities can negatively affect health and social outcomes. We aimed to assess the association between adversity in childhood and use of public services in early adulthood across three systems: health, social welfare, and justice.
-
Inequities in access to assistive technology: a call for action Lancet Public Health (IF 25.4) Pub Date : 2024-12-12 Luc de Witte, Rosalie van der Vaart
Based on existing cross-sectional studies, case studies, and policy-related reports, experts in the field of assistive technology have long suspected that even in high-income countries such as England not everyone who could benefit from assistive technology has access to it, and that there are inequities in access. However, there was little concrete data on the extent of these gaps. Those data have
-
Demographic, socioeconomic, and social barriers to use of mobility assistive products: a multistate analysis of the English Longitudinal Study of Ageing Lancet Public Health (IF 25.4) Pub Date : 2024-12-12 Jamie Danemayer MSc, Mikaela Bloomberg PhD, Adam Mills MSc, Prof Cathy Holloway PhD, Prof Shereen Hussein PhD
Cross-sectional evidence suggests that access to essential mobility assistive products (MAPs) might be dependent on non-clinical factors. However, MAP use is better understood as a dynamic process wherein individuals pass through different states of MAP need and use. We aimed to test associations of demographic, socioeconomic, and social factors with transitions between MAP need and use states.
-
Public health in China: challenges and prospects Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 The Lancet Public Health
This December issue of The Lancet Public Health is our annual themed issue on public health in China. It is dedicated to the 1·4 billion people living in China and to the health-care workers, practitioners, and researchers whose work is featured in this issue and presented at The Lancet-Chinese Academy of Medical Sciences Conference held in Beijing on Nov 21–22. Nowadays, China faces four important
-
Integrating prevention and treatment: rethinking China's health financing Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Zhicheng Wang, Kit Yee Chan, Qianyi Xia, Jiantuo Yu, Minghui Ren
Preventive health measures offer superior economic returns compared with the ever-increasing costs of treating established diseases, which place unsustainable pressure on health systems. By reducing the incidence and severity of illness, prevention minimises health-care expenditure and maximises societal welfare by lowering the burden of disease. In China, the principle of making prevention a priority
-
Associations of long-term nitrogen dioxide exposure with a wide spectrum of diseases: a prospective cohort study of 0·5 million Chinese adults Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Xi Xia PhD, Xia Meng PhD, Cong Liu PhD, Yi Guo MPhil, Xinyue Li MPhil, Yue Niu PhD, Kin Bong Hubert Lam PhD, Neil Wright PhD, Christiana Kartsonaki DPhil, Yiping Chen DPhil, Ling Yang PhD, Huaidong Du PhD, Canqing Yu PhD, Dianjianyi Sun PhD, Prof Jun Lv PhD, Prof Junshi Chen MD, Xiaoming Yang PhD, Ruqin Gao MPhil, Prof Shaowei Wu PhD, Prof Haidong Kan PhD, Ka Hung Chan DPhil, Prof Liming Li PhD, Prof
Little evidence is available on the long-term health effects of nitrogen dioxide (NO2) in low-income and middle-income populations. We investigated the associations of long-term NO2 exposure with the incidence of a wide spectrum of disease outcomes, based on data from the China Kadoorie Biobank.
-
Changes in the epidemiology of under-5 mortality in China from 2016 to 2022: an observational analysis of population-based surveillance data Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Chunhua He MD, Leni Kang PhD, Yuxi Liu MD, Xue Yu MD, Qi Li MD, Prof Juan Liang MD, Prof Li Dai PhD, Prof Xiaohong Li PhD, Prof Yanping Wang MD, Prof Jun Zhu MD, Prof Hanmin Liu PhD
Sustainable Development Goal (SDG) 3.2 aims to end preventable deaths of newborns and children younger than 5 years. China's progress towards SDG 3.2 has not been evaluated on multiple dimensions. We aimed to assess mortality rates in children younger than 5 years (hereafter referred to as under-5 mortality) and to quantify preventable child mortality and geospatial and temporal trends in child mortality
-
Digital mental health: a potential opportunity to improve health equity in China Lancet Public Health (IF 25.4) Pub Date : 2024-12-04 Hao Fong Sit MSc, Prof Wen Chen PhD, Prof Dan Wu PhD MBBS, Yangmu Huang MD, Prof Dong (Roman) Xu PhD MPP, Prof Brian J Hall PhD
Mental health is an important public health issue in China, compounded by a shortage in psychiatric services. Against this backdrop, digital technologies could offer solutions. Digital mental health interventions use technologies, such as smartphone applications, to improve mental health outcomes. Although there has been a drastic increase in mental health mobile apps available in recent years, current
-
All-cause and cause-specific mortality inequalities between people with and without disability: a nationwide data linkage study in Australia Lancet Public Health (IF 25.4) Pub Date : 2024-12-03 Yi Yang PhD, Peter Summers Mbiostat, Zoe Aitken PhD, Prof Anne Kavanagh PhD, George Disney PhD
Without high-quality statistics on mortality inequalities, designing policies to improve the health of people with disability is challenging. We aim to quantify mortality inequalities experienced by people with disability in Australia.
-
Closing the mortality gap for people with disabilities Lancet Public Health (IF 25.4) Pub Date : 2024-12-03 Hannah Kuper, Sara Rotenberg
There are about 1·3 billion people with disability globally, and their higher mortality rates mean that they are dying about 14 years earlier than people without disability.1, 2 In this issue of The Lancet Public Health, Yi Yang and colleagues’ study3 adds to this literature. Using large-scale longitudinal data from 15 million Australians, they showed that people with disability have high inequalities—whether
-
Correction to Lancet Public Health 2024; 9: e295–305 Lancet Public Health (IF 25.4) Pub Date : 2024-11-26
Tetzlaff F, Sauerberg M, Grigoriev P, et al. Age-specific and cause-specific mortality contributions to the socioeconomic gap in life expectancy in Germany, 2003–21: an ecological study. Lancet Public Health 2024; 9: e295–305—In figure 1 of this Article, sex data were plotted incorrectly. This correction has been made as of Nov 25, 2024.
-
Control of childhood obesity and implications for policy in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Yanhui Dong PhD, Prof Changzheng Yuan ScD, Jiajia Dang, Xinli Song, Prof Guo Cheng, Prof Yajun Chen, Prof Haijun Wang, Prof Jie Mi, Prof Bo Xi, Prof Yi Song PhD
Prevention and control of childhood obesity in China is complex. Despite numerous existing policy endeavours, particularly Healthy China 2030, accompanied by multiministerial initiatives, childhood obesity persists and even exacerbates. In this paper, we review current national policies, assess progress of the existing system managing childhood weight, and identify implementation challenges. Leveraging
-
Public health interventions against childhood obesity in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Changzheng Yuan ScD, Prof Yanhui Dong PhD, Hui Chen MS, Prof Le Ma PhD, Prof Lihong Jia PhD, Prof Jiayou Luo PhD, Prof Qin Liu PhD, Prof Yifei Hu PhD, Prof Jun Ma PhD, Prof Yi Song PhD
China is confronted with the challenge of increasing childhood obesity. Although interventions for childhood obesity have been developed, their effectiveness and implementation can vary considerably across nations. In this paper, we review and consolidate the evidence on childhood obesity intervention strategies aimed at multiple levels and components across life, in China. School-based interventions
-
Determinants of childhood obesity in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Changzheng Yuan ScD, Prof Yanhui Dong PhD, Hui Chen MS, Prof Le Ma PhD, Prof Lihong Jia PhD, Prof Jiayou Luo PhD, Prof Qin Liu PhD, Prof Yifei Hu PhD, Prof Jun Ma PhD, Yi Song PhD
Over the past four decades, China has witnessed an important nutritional transition, characterised by a heightened overnutrition burden among children. The country now has the largest population of children with obesity globally. In this paper, we review the epidemiology of childhood obesity in China, its determinants, and risk factors, with a particular focus on school-aged children. Evidence unveils
-
Obesity in China: what we know and what we can do Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Xiong-Fei Pan, Zhong-Ze Fang
Overweight and obesity in children have emerged as a major public health challenge in China. National statistics show that the prevalence of overweight and obesity reached up to 10% in children younger than 6 years and 20% in those aged 6–17 years,1 which is projected to continue rising in the next few years.2 In response to this public health imperative, 16 Chinese national agencies, including the
-
Diabetes in China part 1: epidemiology and risk factors Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Yu Xu PhD, Prof Jieli Lu MD, Mian Li PhD, Prof Tiange Wang PhD, Kan Wang PhD, Qiuyu Cao PhD, Yi Ding MD, Yu Xiang PhD, Siyu Wang BS, Qianqian Yang MS, Xuan Zhao BS, Xiaoyun Zhang MD, Prof Min Xu PhD, Prof Weiqing Wang MD, Prof Yufang Bi MD, Prof Guang Ning MD
The prevalence of diabetes in China is rapidly increasing. China now has the largest number of people living with diabetes worldwide, accounting for approximately one-quarter of the global diabetes population. Since the late 1970s, China has experienced profound changes and rapid economic growth, leading to shifts in lifestyle. Changing dietary patterns, reduced physical activity, and stress have contributed
-
Diabetes in China part 2: prevention, challenges, and progress Lancet Public Health (IF 25.4) Pub Date : 2024-11-20 Prof Yu Xu PhD, Prof Jieli Lu MD, Mian Li PhD, Prof Tiange Wang PhD, Kan Wang PhD, Qiuyu Cao PhD, Yi Ding MD, Yu Xiang PhD, Siyu Wang BS, Qianqian Yang MS, Xuan Zhao BS, Xiaoyun Zhang MD, Prof Min Xu PhD, Prof Weiqing Wang MD, Prof Yufang Bi MD, Prof Guang Ning MD
During the past 40 years, the prevalence of diabetes in China has increased from less than 1·0% in 1980 to 12·4% in 2018, an increase in line with the rapid growth of the nation's economy. To address such a burden, the Healthy China 2030 initiative and subsequent Action Plan, including a diabetes prevention and control campaign, were launched. A shift from a disease-centred approach to a health-centred
-
Implementing comprehensive nationwide smoke-free legislation in China Lancet Public Health (IF 25.4) Pub Date : 2024-11-19 Shiwei Liu, Zhuo Chen
Tobacco use is the leading cause of preventable death globally, accounting for more than 7 million deaths worldwide, including nearly 1·3 million deaths due to second-hand smoke.1 There is no safe threshold of exposure to second-hand smoke, and smoke-free environments are a proven way to adequately protect people from the harmful effects of second-hand smoke without harming businesses.2 Legislation
-
Effects of comprehensive smoke-free legislation on smoking behaviours and macroeconomic outcomes in Shanghai, China: a difference-in-differences analysis and modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-11-19 Hongqiao Fu PhD, Sian Tsuei PhD, Yunting Zheng PhD, Simiao Chen ScD, Shirui Zhu MSc, Duo Xu PhD, Prof Winnie Yip PhD
China has one of the highest levels of tobacco consumption globally, and there is no national smoke-free legislation. Although more than 20 Chinese cities have passed local smoke-free laws since 2008, evidence on their effectiveness in reducing smoking behaviours and their economic benefits is scarce. By exploiting a natural quasi-experiment, whereby a comprehensive public smoking ban was implemented
-
Correction to Lancet Public Health 2024; 9: e834–35 Lancet Public Health (IF 25.4) Pub Date : 2024-11-04
Tan M. Mandatory salt targets: a key policy tool for global salt reduction efforts. Lancet Public Health 2024; 9: e834–35—In this Linked Comment, the fifth sentence of the third paragraph should have said US$8·0 billion. This correction has been made as of Nov 4, 2024.
-
The 2024 China report of the Lancet Countdown on health and climate change: launching a new low-carbon, healthy journey Lancet Public Health (IF 25.4) Pub Date : 2024-11-04 Prof Wenjia Cai PhD, Prof Chi Zhang PhD, Shihui Zhang PhD, Prof Yuqi Bai PhD, Max Callaghan PhD, Nan Chang BM, Prof Bin Chen PhD, Huiqi Chen BM, Liangliang Cheng PhD, Prof Hancheng Dai PhD, Prof Weicheng Fan PhD, Prof Dabo Guan PhD, Yixin Hu PhD, Yifan Hu BS, Junyi Hua PhD, Prof Cunrui Huang PhD, Prof Hong Huang PhD, Jianbin Huang PhD, Prof Xiaomeng Huang PhD, John S Ji Dsc, Qiaolei Jiang PhD, Xiaopeng
2023 was a landmark year for climate change globally, across Asia, and within China. Global average temperatures were 1·45°C higher than the pre-industrial average, making it the warmest year on record since 1850. In Asia, 2023 was the second-hottest year documented. China recorded its highest-ever average temperature at 10·71°C (0·82°C above the 1981–2010 average), had its second-lowest rainfall since
-
Estimated health benefits, costs, and cost-effectiveness of implementing WHO's sodium benchmarks for packaged foods in India: a modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Kathy Trieu PhD, Liping Huang PhD, Leopold N Aminde PhD, Linda Cobiac PhD, Daisy H Coyle PhD, Mary Njeri Wanjau PhD, Sudhir Raj Thout MA, Prof Bruce Neal PhD, Prof Jason H Y Wu PhD, Prof Lennert Veerman PhD, Matti Marklund PhD, Rachita Gupta PhD
Excess dietary sodium intake has been associated with death and disability. WHO has released global sodium benchmarks for packaged foods to support countries to reduce population sodium intake. This study aimed to assess the potential health effect, costs, and cost effectiveness of implementing these WHO sodium benchmarks in India.
-
Mandatory salt targets: a key policy tool for global salt reduction efforts Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Monique Tan
Salt is consumed in excess in most countries, with global salt intake averaging at more than double the recommended maximum limit of 5 g per day. By raising blood pressure, excess salt intake is a major risk factor for cardiovascular disease, the leading cause of premature death and ill health worldwide. In 2013, all WHO Member States committed to a 30% reduction in average salt intake by 2025. However
-
Contemporary heart failure and comorbidity risk management Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Meng Li, Gregory Y H Lip
Heart failure is a global health burden, with an estimated prevalence of more than 56 million individuals worldwide.1 Notably, heart failure is highly associated with poor quality of life, frequent admissions to hospital, rising health-care costs, and high mortality rates. This complex clinical syndrome poses challenges to therapeutic interventions of heart failure, especially since a higher comorbidity
-
Implementation efforts to support transition to HPV-based cervical cancer screening Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Maribel Almonte, María de la Luz Hernández, Prajakta Adsul
On average, it takes 15 years from the landmark publication on a cancer control evidence-based intervention to achieve 50% uptake in routine practice.1 In fact, nearly 20 years have passed since the first observational studies showed that human papillomavirus (HPV) DNA testing had substantially higher sensitivity for detecting cervical precancer and cancer compared with cervical cytology.2 Since then
-
Estimated health effect, cost, and cost-effectiveness of mandating sodium benchmarks in Australia's packaged foods: a modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Matti Marklund PhD, Kathy Trieu PhD, Leopold N Aminde MD, Linda Cobiac PhD, Daisy H Coyle PhD, Liping Huang PhD, Prof Bruce Neal PhD, Prof Lennert Veerman MD, Prof Jason H Y Wu PhD
Excess dietary sodium is a leading cause of death and disability globally. Because packaged foods are a major source of sodium in many countries, including Australia, mandatory limits for sodium might improve population health. We aimed to estimate the long-term health and economic effect of mandating such thresholds in Australia.
-
Contemporary epidemiology of hospitalised heart failure with reduced versus preserved ejection fraction in England: a retrospective, cohort study of whole-population electronic health records Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Robert A Fletcher MSc, Patrick Rockenschaub PhD, Brendon L Neuen PhD, Isabel Johanna Walter MD, Nathalie Conrad DPhil, Mehrdad A Mizani PhD, Thomas Bolton PhD, Claire A Lawson PhD, Christopher Tomlinson MBBS, Stelios Boulitsakis Logothetis MEng, Carmen Petitjean MPhil, Luigi Filippo Brizzi MD, Stephen Kaptoge PhD, Elena Raffetti PhD, Patrick A Calvert PhD, Prof Emanuele Di Angelantonio FMedSci, Prof
Heart failure is common, complex, and often associated with coexisting chronic medical conditions and a high mortality. We aimed to assess the epidemiology of people admitted to hospital with heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), including the period covering the COVID-19 pandemic, which was previously not well characterised
-
Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Jiangrong Wang PhD, K Miriam Elfström PhD, Prof Joakim Dillner MD
Human papillomavirus (HPV)-based cervical screening is a globally recommended public health policy. Randomised clinical trials find superior performance of primary HPV-based screening compared with cytology for preventing cervical cancer. However, additional evidence from real-world public health policies is needed. In preplanned secondary analysis of a randomised health-care policy trial in Sweden
-
City mobility patterns during the COVID-19 pandemic: analysis of a global natural experiment Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Prof Ruth F Hunter PhD, Selin Akaraci PhD, Ruoyu Wang PhD, Prof Rodrigo Reis PhD, Prof Pedro C Hallal PhD, Prof Sandy Pentland PhD, Prof Christopher Millett PhD, Leandro Garcia PhD, Jason Thompson PhD, Kerry Nice PhD, Belen Zapata-Diomedi PhD, Prof Esteban Moro PhD
During the COVID-19 pandemic, changes were seen in city mobility patterns around the world, including in active transportation (walking, cycling, micromobility, and public transit use), creating a unique opportunity for global public health lessons and action. We aimed to analyse a global natural experiment exploring city mobility patterns during the pandemic and how they related to the implementation
-
Alcohol and mortality in Mexico: prospective study of 150 000 adults Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Eirini Trichia PhD, Prof Jesus Alegre-Díaz MD, Diego Aguilar-Ramirez DPhil, Raúl Ramirez-Reyes, Adrián Garcilazo-Ávila PhD, Carlos González-Carballo MSc, Fiona Bragg DPhil, Louisa Gnatiuc Friedrichs DPhil, Prof William G Herrington MD, Lisa Holland PhD, Jason Torres PhD, Rachel Wade MSc, Prof Rory Collins FRS, Prof Richard Peto FRS, Prof Jaime Berumen PhD, Prof Roberto Tapia-Conyer PhD, Prof Pablo
Alcohol consumption is a leading cause of premature death globally, but there is no large-scale prospective evidence from Mexico.
-
50 years of comprehensive state-wide data on pregnancy termination in South Australia: a retrospective, population-based, cohort study Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Laura J Slade MWomHMed, Jennie Louise PhD, Prof Katina D’Onise PhD, Prof Jodie M Dodd PhD
Termination of pregnancy is a common procedure, accessed globally, irrespective of logistical and legal barriers. We aimed to document changes in procedural characteristics and demographic factors over time in South Australia, as well as to examine how key sociodemographic variables affect gestational age at pregnancy termination.
-
Workplace mortality risk and social determinants among migrant workers: a systematic review and meta-analysis Lancet Public Health (IF 25.4) Pub Date : 2024-10-30 Karen Lau MSc, Prof Robert Aldridge PhD, Prof Marie Norredam PhD, George Frederick Mkoma PhD, Mathura Kugan MSc, Rosita Chia-Yin Lin MSc, Ligia Kiss PhD, Prof Cathy Zimmerman PhD, Prof Sally Hargreaves PhD
Migrant workers, a population of 170 million, often work in dangerous or unhealthy working environments and are likely to suffer workplace injuries and labour abuses. However, the risk of mortality in migrant workers compared with local workers is unknown. We aim to synthesise global evidence on migrant worker mortality risk and identify social determinants to inform health and safety protections for
-
Trends and inequalities in thinness and obesity among Chinese children and adolescents: evidence from seven national school surveys between 1985 and 2019 Lancet Public Health (IF 25.4) Pub Date : 2024-10-29 Xinli Song PhD, Bin Zhou PhD, Prof Sarah Baird PhD, Prof Chunling Lu PhD, Prof Majid Ezzati PhD, Li Chen PhD, Jieyu Liu PhD, Yi Zhang MS, Ruolin Wang MS, Qi Ma MS, Jianuo Jiang MS, Yang Qin MS, Ziqi Dong MS, Wen Yuan PhD, Tongjun Guo PhD, Zhiying Song PhD, Yunfei Liu PhD, Jiajia Dang PhD, Peijin Hu PhD, Prof Yanhui Dong PhD, Prof Yi Song PhD, Prof Jun Ma PhD, Prof Susan M Sawyer MD
There are little recent data in China regarding contemporary nutritional inequities among children and adolescents, particularly in relation to urban–rural residence and regional socioeconomic status (SES). We aim to assess inequalities in thinness and obesity in Chinese children and adolescents.
-
Time for a public health response to gambling Lancet Public Health (IF 25.4) Pub Date : 2024-10-24 The Lancet Public Health
Today, we publish the Lancet Public Health Commission on gambling—an inquiry and response to a neglected, understudied, and expanding public health threat. Gambling is not a simple leisure activity; it is a health-harming addictive behaviour. The harms associated with gambling are wide-ranging, not only affecting an individual's health and wellbeing, but also their wealth and relationships, affecting
-
The Lancet Public Health Commission on gambling Lancet Public Health (IF 25.4) Pub Date : 2024-10-24 Prof Heather Wardle PhD, Prof Louisa Degenhardt PhD, Virve Marionneau PhD, Prof Gerda Reith PhD, Charles Livingstone PhD, Prof Malcolm Sparrow PhD, Lucy T Tran MSc, Blair Biggar PhD, Prof Christopher Bunn PhD, Prof Michael Farrell PhD, Viktorija Kesaite PhD, Vladimir Poznyak MD, Jianchao Quan MD, Prof Jürgen Rehm PhD, Angela Rintoul PhD, Prof Manoj Sharma PhD, Prof Jeremy Shiffman PhD, Kristiana Siste
The global gambling industry is rapidly expanding, with net losses by consumers projected to reach nearly US$700 billion by 2028. Industry growth is fuelled by the rise of online gambling, widespread accessibility of gambling opportunities through mobile phones, increased legalisation, and the introduction of commercial gambling to new areas. Recent expansion is most notable in low-income and middle-income
-
Cancer risk and legalisation of access to cannabis in the USA: overview of the evidence Lancet Public Health (IF 25.4) Pub Date : 2024-10-18 Nigar Nargis, J Lee Westmaas, Eva Orr, Mohammed M Alqahtani, Parichoy Pal Choudhury, Farhad Islami, Ahmedin Jemal
Cannabis in the USA is transitioning from a nationwide illegal status to liberalisation for medicinal or recreational use across different jurisdictions. As the acceptability and accessibility of cannabis continue to grow, updated knowledge on the cancer risk from recreational cannabis use is necessary to inform recommendations by public health organisations, policy makers, and clinical practitioners
-
Mass incarceration as a driver of the tuberculosis epidemic in Latin America and projected effects of policy alternatives: a mathematical modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-10-15 Yiran E Liu PhD, Yasmine Mabene BSc, Sergio Camelo MSc, Zulma Vanessa Rueda PhD, Daniele Maria Pelissari PhD, Fernanda Dockhorn Costa Johansen MD, Moises A Huaman MD, Tatiana Avalos-Cruz MD, Valentina A Alarcón MD, Lawrence M Ladutke PhD, Prof Marcelo Bergman PhD, Prof Ted Cohen DPH, Prof Jeremy D Goldhaber-Fiebert PhD, Julio Croda PhD, Prof Jason R Andrews MD
Tuberculosis incidence is increasing in Latin America, where the incarcerated population has nearly quadrupled since 1990. We aimed to quantify the impact of historical and future incarceration policies on the tuberculosis epidemic, accounting for effects in and beyond prisons.
-
Area-level socioeconomic inequalities in mortality in China: a nationwide cohort study based on the ChinaHEART project Lancet Public Health (IF 25.4) Pub Date : 2024-10-15 Wenyao Peng BS, Siqi Lin BS, Bowang Chen PhD, Xueke Bai MS, Chaoqun Wu MS, Xiaoyan Zhang MS, Yang Yang MSA, Jianlan Cui MS, Wei Xu MS, Lijuan Song MS, Hao Yang BS, Wenyan He BSM, Yan Zhang BS, Prof Xi Li PhD, Jiapeng Lu PhD
Socioeconomic status is a key social determinant of health. Compared with individual-level socioeconomic status, the association between area-level socioeconomic status and mortality has not been well investigated in China. We aimed to assess associations between area-level socioeconomic status and all-cause mortality and cause-specific mortality in China, as well as the interplay of area-level and
-
68th Society for Social Medicine & Population Health Annual Scientific meeting Lancet Public Health (IF 25.4) Pub Date : 2024-10-15 Sophie Howard
Rosanna Maletta (Department of Psychology, University of Liverpool, Liverpool, UK) presented a study to understand how discrimination could affect mental health. Indeed, repeated discrimination could result in a build-up of resilience, or a cumulative negative effect could develop. Data from the UK Household Longitudinal Study waves 2015–20 were used. In the cohort of 3863 people, 24% of participants
-
Tuberculosis and incarceration: uncovering the broader picture Lancet Public Health (IF 25.4) Pub Date : 2024-10-15 Alvaro Schwalb, Lara Goscé, Rein M G J Houben
Understanding structural determinants is crucial in addressing tuberculosis, as these factors define the context in which the disease impacts populations. Incarceration has, in recent years, emerged as a major driver for tuberculosis in Latin America.1, 2 Although tuberculosis notification rates among the general population have remained stable, rates among people deprived of liberty have rapidly escalated
-
Educational and income inequalities across diseases in Denmark: a register-based cohort study Lancet Public Health (IF 25.4) Pub Date : 2024-10-05 Anna Vera Jørring Pallesen MSc, Prof Jochen O Mierau PhD, Frederik Kølby Christensen BSc, Prof Laust Hvas Mortensen PhD
Educational attainment and income are often, but not always, associated with disease incidence. Existing research typically examines single diseases, resulting in disparate analyses with little comparability. In this study, we aimed to assess educational and income inequalities across diseases in Denmark.
-
Pregnancy, overweight, and obesity: time to invest in preventive strategies Lancet Public Health (IF 25.4) Pub Date : 2024-10-02 Anna Akselsson
Overweight and obesity are important public health issues and contribute to an increased risk of several diseases, negatively affect reproduction, and decrease quality of life. According to WHO, 43% of adults worldwide are overweight and 16% have obesity. Obesity is a contributing factor to infertility and being overweight increases risks during pregnancy for the mother and the child.1 Furthermore
-
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Lancet Public Health (IF 25.4) Pub Date : 2024-10-02
BackgroundSmoking is the leading behavioural risk factor for mortality globally, accounting for more than 175 million deaths and nearly 4·30 billion years of life lost (YLLs) from 1990 to 2021. The pace of decline in smoking prevalence has slowed in recent years for many countries, and although strategies have recently been proposed to achieve tobacco-free generations, none have been implemented to
-
Estimated impact of a tobacco-elimination strategy on lung-cancer mortality in 185 countries: a population-based birth-cohort simulation study Lancet Public Health (IF 25.4) Pub Date : 2024-10-02 Julia Rey Brandariz, Harriet Rumgay, Olalekan Ayo-Yusuf, Richard Edwards, Farhad Islami, Shiwei Liu, Mónica Pérez-Ríos, Paulo César Rodrigues Pinto Corrêa, Alberto Ruano-Ravina, Isabelle Soerjomataram
BackgroundThe tobacco-free generation aims to prevent the sale of tobacco to people born after a specific year. We aimed to estimate the impact of eliminating tobacco smoking on lung-cancer mortality in people born during 2006–10 in 185 countries. MethodsFor this population-based birth-cohort simulation study, we proposed a scenario in which tobacco sales were banned for people born between Jan 1,
-
Vaping among adults in England who have never regularly smoked: a population-based study, 2016–24 Lancet Public Health (IF 25.4) Pub Date : 2024-10-02 Sarah E Jackson, Lion Shahab, Harry Tattan-Birch, Jamie Brown
BackgroundE-cigarettes are increasingly used by smokers and ex-smokers, often to support smoking cessation, but also among those who have never regularly smoked. The aim of our study is to estimate time trends in vaping prevalence among adults who have never regularly smoked and describe the profile of adult never-regular-smokers who vape. MethodsIn this nationally representative, monthly cross-sectional
-
Adverse pregnancy outcomes attributable to overweight and obesity across maternal birth regions: a Swedish population-based cohort study Lancet Public Health (IF 25.4) Pub Date : 2024-10-02 Maryam Shirvanifar, Viktor H Ahlqvist, Michael Lundberg, Kyriaki Kosidou, Ángel Herraiz-Adillo, Daniel Berglind, Cecilia Magnusson, Pontus Henriksson
BackgroundWhether there are differences in the contribution of overweight and obesity to adverse pregnancy outcomes between migrant and non-migrant women in high-income countries, which might increase health inequalities, remains unclear. Therefore, in this study, we aimed to estimate the contribution (including the proportion and number of attributable cases) of overweight and obesity to a wide range
-
Long-term waning of vaccine-induced immunity to measles in England: a mathematical modelling study Lancet Public Health (IF 25.4) Pub Date : 2024-09-26 Alexis Robert PhD, Anne M Suffel PhD, Prof Adam J Kucharski PhD
Among people infected with measles in England between 2010 and 2019, the proportion of cases who had previously received two doses of vaccine has increased, especially among young adults. Possible explanations include rare infections in vaccinated individuals who did not gain immunity upon vaccination, made more common because fewer individuals in the population were born in the endemic era, before
-
The Sheffield model's influence in informing alcohol control policy Lancet Public Health (IF 25.4) Pub Date : 2024-09-16 Mark Robinson, Jaithri Ananthapavan
Increasing the price of alcohol to reduce its affordability has been the cornerstone of alcohol control efforts for decades. WHO considers this approach among the best buy interventions, with substantial evidence showing that raising alcohol prices—through increased taxation or minimum pricing—is associated with reduced population-level alcohol consumption and related harms.1 However, introducing such
-
Estimating the effect of transitioning to a strength-based alcohol tax system on alcohol consumption and health outcomes: a modelling study of tax reform in England Lancet Public Health (IF 25.4) Pub Date : 2024-09-16 Damon Morris PhD, Colin Angus MSc, Duncan Gillespie PhD, Abigail K Stevely PhD, Robert Pryce PhD, Luke Wilson PhD, Madeleine Henney MSc, Prof Petra S Meier PhD, Prof John Holmes PhD, Prof Alan Brennan PhD
Increasing the amount of alcohol taxation is among the most effective measures for addressing the rising global burden of alcohol harm. However, less is known about the effect of changing alcohol tax structures. Substantial reforms to UK alcohol taxation structures enacted in August, 2023, mean that all alcohol is taxed based on its ethanol content, beers and ciders sold in on-trade premises (eg, public
-
Preventing suicide: a public health approach to a global problem Lancet Public Health (IF 25.4) Pub Date : 2024-09-10 Prof Jane Pirkis PhD, Prof Rakhi Dandona PhD, Prof Morton Silverman MD, Prof Murad Khan PhD, Prof Keith Hawton FMedSci
Suicide is prevalent in all countries and is largely preventable. The causes of suicide are multiple and varied. Social determinants of suicide are crucial, but to date these have received insufficient policy attention. This paper, which is the first in a Series on taking a public health approach to suicide prevention, argues for a major change in the way we think about suicide and its prevention.
-
Addressing key risk factors for suicide at a societal level Lancet Public Health (IF 25.4) Pub Date : 2024-09-10 Prof Jane Pirkis PhD, Prof Jason Bantjes PhD, Prof Rakhi Dandona PhD, Duleeka Knipe PhD, Alexandra Pitman PhD, Prof Jo Robinson PhD, Prof Morton Silverman MD, Prof Keith Hawton FMedSci
A public health approach to suicide prevention recognises the powerful influence of social determinants. In this paper—the fifth in a Series on a public health approach to suicide prevention—we consider four major risk factors for suicide (alcohol use, gambling, domestic violence and abuse, and suicide bereavement) and examine how their influence on suicide is socially determined. Cultural factors
-
Cultures, contexts, and learning opportunities in suicide prevention Lancet Public Health (IF 25.4) Pub Date : 2024-09-10 Lai Fong Chan
The Lancet Public Health Series on public health approaches to suicide prevention, led by Jane Pirkis and Keith Hawton, is timely and important because it highlights the latest evidence for preventing suicide based on a public health model. With more than three quarters of the world's suicides occurring in low-income and middle-income countries (LMICs), it is important to shed light on suicide prevention
-
Restriction of access to means used for suicide Lancet Public Health (IF 25.4) Pub Date : 2024-09-10 Prof Keith Hawton FMedSci, Duleeka Knipe PhD, Prof Jane Pirkis PhD
One of the most effective public health measures to prevent suicide is the restriction of access to means used in suicidal acts. This approach can be especially effective if a method is common and readily accessible. Suicide methods vary widely, and there have been several examples where means restriction has been applied, often with considerable success. Factors contributing to availability of suicide